The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on safety, tolerability and efficacy

The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on safety, tolerability and efficacy

Background aims Mesenchymal stromal cells (MSCs) are characterized by paracrine and immunomodulatory functions capable of changing the microenvironment of damaged brain tissue toward a more regenerative and less inflammatory milieu. The authors conducted a phase 2, single-center, assessor-blinded ra...

Full description

Bibliographic Details
Main Authors: Zhe, Kang Law, Hui, Jan Tan, Sze, Piaw Chin, Chee, Yin Wong, Wan Yahya, Wan Nur Nafisah, Muda, Ahmad Sobri, Zakaria, Rozman, Ariff, Mohd Izhar, Ismail, Nor Azimah, Soon, Keng Cheong, S. Abdul Wahid, S. Fadilah, Mohamed Ibrahim, Norlinah
Format: Article
Language:English
Published: Elsevier 2021
Online Access:http://psasir.upm.edu.my/id/eprint/95417/1/The%20effects%20of%20intravenous%20infusion%20of%20autologous%20mesenchymal%20stromal%20cells%20in%20patients%20with%20subacute%20middle%20cerebral%20artery%20infarct%20a%20phase%202%20randomized%20controlled%20trial%20on%20safety%2C%20tolerability%20and%20efficacy.pdf

Internet

http://psasir.upm.edu.my/id/eprint/95417/1/The%20effects%20of%20intravenous%20infusion%20of%20autologous%20mesenchymal%20stromal%20cells%20in%20patients%20with%20subacute%20middle%20cerebral%20artery%20infarct%20a%20phase%202%20randomized%20controlled%20trial%20on%20safety%2C%20tolerability%20and%20efficacy.pdf

Similar Items